Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Indications for jejunostomy, ileostomy or colostomy vary in the neonatal population. The most common etiologies are congenital anomalies, such as anorectal malformations, intestinal atresia or Hirschsprung's disease, but also acquired conditions, such as enterocolitis or intestinal perforation. The aim of these stomas is to divert stool in the event of intestinal obstruction or risk of fecal contamination.
Depending on the indication and the type of stoma used, the post-operative follow-up, such as resumption of intestinal transit and feeding, secondary closure of the stoma or not, and the duration and cost of hospitalization differ.
The aim of this study is to compare these differences in order to extract an optimal management strategy, in the light of what is reported in the international scientific literature.
The investigators gathered the data of patients born between January 2009 and December 2023, who had an ostomy made during the first three months of their life.
The investigators then analyzed the patients outcomes ( postoperative complications, length of stay, cost of hospitalization) depending on the etiology of their primary disease.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hirschsprung's Disease | Patients with Hirschsprung's Disease who had a stoma in the first 3 months of life | ||
| Anorectal MAlformations | Patients with Anorectal MAlformations who had a stoma in the first 3 months of life | ||
| Intestinal Atresia | Patients with Intestinal Atresia who had a stoma in the first 3 months of life | ||
| Necrotizing Enterocolitis | Patients with Necrotizing Enterocolitis who had a stoma in the first 3 months of life | ||
| Intestinal Perforations | Patients with Intestinal Perforations who had a stoma in the first 3 months of life |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative medical complications | infections, sepsis, dehydration, hydroelectrolytic disorders | through study completion, an average of 1 year |
| Postoperative surgical complications | disunion, surgical scar, | through study completion, an average of 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Length of stay | time of hospitalization | through study completion, an average of 1 year |
| Hospitalization costs | costs by department and overall costs |
| Measure | Description | Time Frame |
|---|---|---|
| Redo | Necessity to remake the stoma | through study completion, an average of 1 year |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Neonates whose disease require a stoma during the first 3 months of life, from January 2009 to December 2023
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christelle Destinval, MD | University Hospital, Clermont-Ferrand | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clermont-Ferrand University Hospital | Clermont-Ferrand | Auvergne | 63000 | France |
Not provided
| ID | Term |
|---|---|
| D007232 | Infant, Newborn, Diseases |
| ID | Term |
|---|---|
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided
Not provided
Not provided
Not provided
| through study completion, an average of 1 year |